Histamine dihydrochloride use
in leukemia
Histamine dihydrochloride is an
amine acquired by enzymatic decarboxylation of HISTIDINE. It is a able
analeptic of belly secretion, a constrictor of bronchial bland muscle, a
vasodilator, and aswell a centrally acting neurotransmitter.
Histamine dihydrochloride is
administered in affiliation with low doses of the immune-activating cytokine
interleukin-2 (IL-2) in the post-remission appearance of AML, i.e. if patients
accept completed the antecedent chemotherapy. This aggregate has been appear to
decidedly abate the accident of backsliding in AML. The effect is decidedly
arresting in patients in their aboriginal absolution who are beneath the age of
60.
The aggregate of histamine
dihydrochloride and interleukin-2 was accustomed for use in AML patients aural
the European Union in October 2008 and will be marketed in the EU by the
Swedish biologic aggregation Meda. The biologic is aswell accessible through a
called accommodating affairs in several added countries (excluding the US).
没有评论:
发表评论